In summary, our results demonstrated that both HAS2-AS1 and USF1 were highly expressed in glioma tissues and cells, and USF1 could bind to the HAS2-AS1 promoter region to activate the transcription of HAS2-AS1, thus promoting the migration and invasion of glioma cells. Here, HAS2 is linked to central nervous system cancer.